4LSC2610 [13C6]-Glucosylsphingosine / [13C6]-GlcSph

Catalog Number: 4LSC2610

CAS #: N/A

Related CAS #: 52050-17-6 (unlabeled)

Name: [¹³C₆]-Glucosylsphingosine, [¹³C₆]-GlcSph, [¹³C₆]-D-Glucosylsphingosine, (2R,3R,4S,5S,6R)-2-(((2S,3R,E)-2-amino-3-hydroxyoctadec-4-en-1-yl)oxy)-6-(hydroxymethyl-13C)tetrahydro-2H-pyran-3,4,5-triol-2,3,4,5,6-13C5

Molecular Formula: C₁₈¹³C₆H₄₇NO₇

Molecular Weight: 467.59 g/mol

Specification:

Minimum purity: 95.0 %
Minimum Isotopic Enrichment: ¹³C ≥99 %

Product Description: N/A

Glucosylsphingosine (GlcSph) is a key biomarker of Gaucher Disease (GD). Stable isotope labeled Glucosylsphingosine (GlcSph) is intended for use as an internal standard for the quantification of Glucosylsphingosine by LC or GC-mass spectrometry.

If the number, nature and/or location of stable isotope label atoms (D, ¹⁵N, ¹³C) in this molecule don’t fit with your application, don’t hesitate to contact us to discuss your specific needs.

Keywords:

Stable isotope labeled active pharmaceutical ingredient (API),  stable isotope dilution analysis, internal standard, stable isotope labeled standard (SIL), therapeutic drug monitoring (TDM), quantitative bioanalytical method validation, clinical diagnostic, LC/MS method validation.